Valladolid R&D Projects

Curia Spain, S.A.U. develops during the years 2021 to 2024 a new project whose main objective is to develop new robust chemical synthesis processes for the industrial production of 4 active ingredients that will be used in the manufacture of generic drugs to alleviate different conditions.

On July 9, 2021, the President of the Castilla y León Institute for Business Competitiveness issues a resolution by which the project, "DEVELOPMENT OF NEW ACTIVE PRINCIPLES FOR GENERIC MEDICINES" is financed by the European Regional Development Fund (ERDF) of the European Union and the Junta de Castilla y León, through the Institute for Business Competitiveness of Castilla y León (ICE), with the aim of promoting research, technological development and innovation.